Item request has been placed! ×
Item request cannot be made. ×
Most Popular Articles from JAMA & NEJM
Indoor Air Changes and Potential Implications for SARS-CoV-2 TransmissionMost Read Articles from JAMAApr 16th 2021
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingMost Viewed Articles from NEJMApr 15th 2021
Thrombotic Thrombocytopenia after Ad26.COV2.S VaccinationMost Viewed Articles from NEJMApr 14th 2021
SARS-CoV-2 Antibody Response in Persons with Past Natural InfectionMost Viewed Articles from NEJMApr 14th 2021
Effect of Weekly Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or ObesityMost Read Articles from JAMAApr 13th 2021
Contact the Library
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinomaCochrane.orgApr 18th 2021
What surgical procedure works best to slow the progression of keratoconus (an eye disease)?Cochrane.orgApr 16th 2021
Detailed guide: Regulatory status of equipment being used to help prevent coronavirus (COVID-19)MHRAApr 9th 2021
Older Adults' Experiences With the Visual Physio-Feedback Technology and Peer-Led Combined Group and Home-Based Exercises.
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.